Complement as Prognostic Biomarker and Potential Therapeutic Target in Renal Cell Carcinoma is a research paper published in The Journal of Immunology (2020). On theSindex it has a DataRank of 0. It has been cited 46 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute, National Institutes of Health
Grant: R01CA190209
National Cancer Institute, National Institutes of Health
Grant: P50CA196516
Cancer Prevention and Research Institute of Texas
Grant: RP190208
National Institutes of Health
Grant: 5P50CA196516-05
The University of Texas Southwestern Medical Center SPORE in Kidney Cancer
National Institutes of Health
Grant: 3P30CA142543-12S1
Multidimensional single-cell approach probing HIV-1 integration association with non-AIDS defining cancers (Biospecimens/Biocohort)
National Institutes of Health
Grant: 5R01CA190209-02
Targeting the Premetastatic Niche by Antiangiogenic Immunotherapy
NCI NIH HHS
Grant: P30 CA142543
FWCI
1.43
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals